Amanote Research
Register
Sign In
Retraction of WHO Guidance on Opioid Use
Bulletin of the World Health Organization
- Switzerland
doi 10.2471/blt.19.249417
Full Text
Open PDF
Abstract
Available in
full text
Categories
Environmental
Public Health
Occupational Health
Date
January 1, 2020
Authors
Unknown
Publisher
WHO Press
Related search
New Canadian Guidance on Opioid Use for Chronic Pain: Necessary but Not Sufficient
CMAJ
Medicine
P-88 Management of Hospice Patients Who Use Prescribed Intravenous Diamorphine for Opioid Addiction
Initiation Into Prescription Opioid Injection and Associated Trends in Heroin Use Among People Who Use Illicit Drugs
Drug and Alcohol Dependence
Psychiatry
Toxicology
Mental Health
Pharmacology
Addressing Opioid Use Disorder in Modeling Hepatitis C Transmission Among Persons Who Inject Drugs
Hepatology
Medicine
Hepatology
Who Benefits From Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
Healthcare
Potential Impact of Medical Marijuana on Nonmedical Opioid Use
American Journal of Psychiatry
Psychiatry
Mental Health
Reasons for Not Using a Specific Health Guidance System: Focusing on Persons Insured by the National Health Insurance Program Who Do Not Use Specific Health Guidance
Journal of Japan Academy of Nursing Science
Opioid Use Is Rising
Anesthesiology
Anesthesiology
Pain Medicine
Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder
JAMA network open
Medicine
